Research

New SOP Master’s Program Welcomes Inaugural Class

October 2, 2012

Designed for current professionals, the MS in Pharmaceutical Sciences (Pharmacometrics) program aims to cultivate scientific leaders in the growing field of pharmacometrics.

Dean Eddington Named Chair of NIPTE Board of Directors

September 18, 2012

Eddington becomes third person to hold this important position since organization’s inception in 2007

Industry, FDA Call for Strides in Regulatory Science at UM Center Launch

September 14, 2012

Center of Excellence in Regulatory Science and Innovation taps researchers at Baltimore and College Park campuses, Food and Drug Administration, and industry to make a difference.

School of Pharmacy Launches New Website, Pharmacy Portal

August 20, 2012

New design and improved functionality enhances visitors’ experience and assists the School in promoting its mission to lead pharmacy education, scientific discovery, patient care, and community engagement in the state of Maryland and beyond

PhD Student Wins ACS Medicinal Chemistry Pre-doctoral Fellowship

July 31, 2012

Graduate student in the Department of Pharmaceutical Sciences is the first University System of Maryland student to earn prestigious fellowship

School of Pharmacy Hosts Symposium Focused on Computer-aided Drug Design

July 23, 2012

Attendees learn about CADD Center’s capabilities and hear from leaders in the field

UM-CERSI Awards Inaugural Innovation Awards

March 21, 2012

Funded projects are collaborations between faculty in Baltimore, College Park, and staff at the FDA

SOP Teams With College Park on FDA Drug Regulatory Science Initiative

November 3, 2011

The University of Maryland has assembled an interprofessional team of research scientists from its campuses in Baltimore and College Park for a center of excellence.

Leading Drug Epidemiologist Endorses New Psychotropic Guidelines for Youth

October 21, 2009

University of Maryland School of Pharmacy professor welcomes guidelines to ensure better child safety and reduce the risk of inappropriate prescriptions.